Saniona AB SANION
OMXSTO · Sweden · Health Technology
SEK 9.45-0.31 (-3.18%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Saniona AB (LTS:0RQJ) narrows focus to SAN2668 and SAN2465, reporting a SEK58 million net loss while securing non-dilutive funding and advancing toward key clinical milestones.
Saniona AB (FRA:30S) strengthens its CNS pipeline and financial position despite facing increased competition and funding needs.
As European markets navigate a period of volatility, with the STOXX Europe 600 Index recently hitting new highs amid concerns over AI disruption, investors are keeping a keen eye on small-cap stocks that could offer unique opportunities. In this dynamic environment, identifying stocks that demonstrate resilience and potential for growth can be key to uncovering undiscovered gems in the region.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.